News
The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...
US President Donald Trump’s recent weight loss has become the talk of the town after his recent medical exam revealed a ...
TALLMADGE, Ohio, April 24, 2025 (GLOBE NEWSWIRE) -- 2025 study stated Mitolyn is a cellular energy support supplement that ...
This brings us to Nourix, a brand-new weight-loss pill that claims to make losing weight easier and healthier. Rather than ...
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.
Made in the USA, a new daily oral weight-loss pill from Eli Lilly won't require cold storage and is expected to hit markets ...
Lilly's announcement that it would make its experimental weight-loss pill in the U.S. comes amid administration pressure on ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its ...
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...
A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results